Breast Cancer Clinical Trial
Official title:
An Intervention to Improve Decision Role Concordance Amongst Newly Diagnosed Breast Cancer Patients
The goal of this project is to test the effects of the Patient Preference Scale as the basis for a clinical intervention for role negotiation in breast cancer surgery decisions and the Patient Perception Scale to measure role concordance. The investigators hypothesize that better role concordance will be achieved with a simple provider-based intervention. In the first half of the study, providers will be blind to the patient's preferred role. In the second half, providers will be made aware of the preferred role prior to the encounter and will have a brief conversation with the patient about their desired role in the decision making process.
The goal of this project is to test the effects of the Patient Preference Scale as the basis
for a clinical intervention for role negotiation in breast cancer surgery decisions and the
Patient Perception Scale to measure role concordance. The investigators hypothesize that
better role concordance will be achieved with a simple provider-based intervention. In
addition, role concordance will be associated with improved short-term and longer-term
improvements in outcomes of the following parameters: a) satisfaction with decision process
b) breast specific QOL, and c) decision regret.
The investigators propose a mixed methods, interventional study with concurrent controls
performed in a breast cancer surgery clinic at a comprehensive cancer center. The Patient
Preference Scale will be used to identify the preferred involvement in decision making of
newly diagnosed breast cancer patients prior to their first clinic visit. The Patient
Perception Scale will be used after the encounter in order to evaluate role concordance. The
Provider Perception Scale will also be used to assess the perception of the achieved role by
the provider. In the first half of the study, providers will be blind to the patient's
preferred role. In the second half, providers will be made aware of the preferred role prior
to the encounter and will have a brief conversation with the patient about their desired role
in the decision making process. Clinical encounters will be audiotaped, transcribed, and
scored for patient involvement. The investigators propose the following aims and hypotheses:
Investigate the impact of a brief provider-led intervention about the patients' preferred
role in treatment decision making on role concordance. The investigators hypothesize that:
1. Role concordance will be improved when the preferred role is discussed with the patient at
the beginning of the encounter.
2. The provider's perception of the role achieved will be more concordant with the patient's
perception when the preferred role is discussed. 3. Investigate the impact of role
concordance in the treatment decision making process on short term and long term quality of
life and decision outcomes. The investigators hypothesize that: Patients who achieve role
concordance will be more satisfied with the decision process.
1. Patients who achieve role concordance will have better QOL and less decision regret at
early (2 to 6 weeks) and later (6 months) time points after the clinic visit.
2. Patients who achieve concordance will be more likely to complete or plan to complete
recommended treatments.
3. Patients who achieve concordance will be more likely to complete or plan to complete
recommended treatments
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Recruiting |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Recruiting |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A |